岡本 浩 | (株) セイシン企業
スポンサーリンク
概要
論文 | ランダム
- Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease
- Rosiglitazone and 15-deoxy-Delta12, 14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut
- Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone
- An open-label trial of the PPARγ ligand rosiglitazone for active ulcerative colitis
- Menkes 病モデルマウスの遺伝子異常と銅代謝